Authors: Valent, F Schernthaner, GH Sperr, WR Fritsch, G Agis, H Willheim, M Buhring, HJ Orfao, A Escribano, L

Citation: F. Valent et al., Variable expression of activation-linked surface antigens on human mast cells in health and disease, IMMUNOL REV, 179, 2001, pp. 74-81

Authors: Samorapoompichit, P Kiener, HP Schernthaner, GH Jordan, JH Agis, H Wimazal, F Baghestanian, M Rezaie-Majd, A Sperr, WR Lechner, K Valent, P

Citation: P. Samorapoompichit et al., Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms, BLOOD, 98(8), 2001, pp. 2580-2583

Authors: Schernthaner, GH Jordan, JH Ghannadan, M Agis, H Bevec, D Nunez, R Escribano, L Majdic, O Willhelm, M Worda, C Printz, D Fritsch, G Lechner, K Valent, P

Citation: Gh. Schernthaner et al., Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells, BLOOD, 98(13), 2001, pp. 3784-3792

Authors: Agis, H Weltermann, A Mitterbauer, G Thalhammer, R Edelhauser, M Seewann, HL Valent, P Lechner, K Fonatsch, C Geissler, K

Citation: H. Agis et al., Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia, ANN HEMATOL, 78(7), 1999, pp. 329-332

Authors: Sillalber, C Baghestanian, M Bevec, D Willheim, M Agis, H Kapiotis, S Fureder, W Bankl, HC Kiener, HP Speiser, W Binder, BR Lechner, K Valent, P

Citation: C. Sillalber et al., The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis, J IMMUNOL, 162(2), 1999, pp. 1032-1041

Authors: Wimazal, F Ghannadan, M Muller, MR End, A Willheim, M Meidlinger, P Schernthaner, GH Jordan, JH Hager, W Agis, H Sperr, WR Czerwenka, K Lechner, K Valent, P

Citation: F. Wimazal et al., Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multicolor flow cytometry and toluidine blue/immunofluorescence staining techniques, TISSUE ANTI, 54(5), 1999, pp. 499-507